Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients
Clinical trial NCT05634525 · WITHDRAWN
Trial details
- NCT number
- NCT05634525
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-03
- Primary completion
- 2025-07-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.